Stay updated on Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page
- ChecktodayChange DetectedA new Study Status row has been added to the history, and a new version (51) was recorded on 2026-07-14. An older history entry dated 2026-04-22 was removed.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision label on the page updated from v3.6.2 to v3.6.3, signifying a newer version of the page in the study history and likely minor maintenance updates.SummaryDifference0.1%

- Check22 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the record history page.SummaryDifference0.1%

- Check36 days agoChange DetectedThe history now shows the study is no longer looking for participants, indicating enrollment has ceased. The entries also add a new revision label v3.6.0 as the current version, replacing the previous v3.5.5 reference.SummaryDifference0.2%

- Check43 days agoChange DetectedThe history shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a new revision of the record was posted to update the entry.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page's revision label updates from v3.5.3 to v3.5.4. This represents a minor backend update affecting the record-history display.SummaryDifference0.1%

Stay in the know with updates to Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab ± Tremelimumab Combo in Untreated ES-SCLC Clinical Trial page.